Skip to main content
. Author manuscript; available in PMC: 2018 Dec 17.
Published in final edited form as: Appl Radiat Isot. 2017 May 10;127:52–60. doi: 10.1016/j.apradiso.2017.05.006

Table 1.

Biodistribution of [203Pb]DOTA-PEG4-VMT-MCR1 and [212Pb]DOTA-PEG4-VMT-MCR1 in C57BL/6 mice bearing B16F1 murine melanoma tumors at 1 h and 3 h post tail vein injection. Data presented as percent injected dose per gram of tissue/blood (%ID/g; n = 3 for each time point for each tissue ± SD).

1 h
3 h
Tissue Pb-203 Pb-212 Pb-203 Pb-212

(%ID/g) (%ID/g) (%ID/g) (%ID/g)
Blood 0.94 ± 0.30 1.05 ± 0.17 0.40 ± 0.02 0.17 ± 0.05
Heart 0.41 ± 0.13 0.62 ± 0.10 0.30 ± 0.07 0.19 ± 0.04
Liver 0.88 ± 0.08 0.49 ± 0.05 0.56 ± 0.03 0.35 ± 0.02
Kidneys 17.18 ± 1.30 14.76 ± 1.32 9.92 ± 1.44 10.65 ± 0.15
Lung 0.82 ± 0.38 1.00 ± 0.03 0.54 ± 0.08 0.33 ± 0.04
Tumor 5.20 ± 2.17 5.50 ± 0.23 5.27 ± 0.73 4.08 ± 0.46
Spleen 0.35 ± 0.18 0.52 ± 0.15 0.50 ± 0.04 0.31 ± 0.02
Muscle 0.14 ± 0.03 0.30 ± 0.03 0.18 ± 0.01 0.19 ± 0.07
Brain 0.04 ± 0.00 0.09 ± 0.02 0.06 ± 0.02 0.05 ± 0.01